NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis

Measurement of the activated partial thromboplastin time from a capillary (fingerstick) sample of whole blood. A new method for monitoring heparin therapy.

Author(s): Ansell J, Tiarks C, Hirsh J, McGehee W, Adler D, Weibert R

Publication: Am J Clin Pathol, 1991, Vol. 95, Page 222-7

PubMed ID: 1992612 PubMed Review Paper? No

Purpose of Paper

The purpose of this paper was to determine the effects of using capillary (whole blood) versus venous (plasma and whole blood) specimens, method of measurement, and type of auto analyzer reagents on activated partial thromboplastin time (aPTT) measurements.

Conclusion of Paper

aPTT measurements from capillary whole blood and venous whole blood measured on the portable 512 Coagulation Monitor were very strongly correlated. Strong correlations were also observed between capillary blood aPTT measured by the portable instrument and venous plasma aPTT measured using standard methods, regardless of reagent type. Further, a strong correlation was seen between plasma aPTT measured using two types of reagents.

Studies

  1. Study Purpose

    The purpose of this study was to determine the effects of using capillary (whole blood) versus venous (plasma and whole blood) specimens, method of measurement, and type of auto analyzer reagents on aPTT in specimens from patients on anticoagulant therapy and normal controls. Venous blood to be used for standard plasma aPTT measurement was placed on ice for an undisclosed amount of time prior to centrifugation.

    Summary of Findings:

    aPTT measurements from capillary whole blood and venous whole blood measured on the portable 512 Coagulation Monitor were very strongly correlated (r=0.93). Strong correlations were also observed between capillary blood aPTT measured by the portable instrument and venous plasma aPTT measured using standard analyzers and either Dade Actin FS reagents or General Diagnostics reagents (r=0.79-0.83). Further, a strong correlation was seen between plasma aPTT measured using both types of reagents (r=0.79). Hematocrit had no effect on venous whole blood aPTT measured by the portable monitor, and the authors state that platelet counts also had no correlation with aPTT.

    Biospecimens
    Preservative Types
    • None (Fresh)
    Diagnoses:
    • Normal
    • Other diagnoses
    Platform:
    AnalyteTechnology Platform
    Morphology Hematology/ auto analyzer
    Cell count/volume Hematology/ auto analyzer
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    Biospecimen Acquisition Method of fluid acquisition Finger/heel prick sampling
    Venipuncture
    Biospecimen Aliquots and Components Blood and blood products Plasma
    Whole blood
    Hematology/ auto analyzer Specific Technology platform 512 Coagulation Monitor (portable)
    MLA 750
    MLA 700
    Hematology/ auto analyzer Specific Reaction solution Dade Actin FS reagents
    General Diagnostics reagents
    Preaquisition Diagnosis/ patient condition Receiving heparin and/or warfarin anticoagulation therapy
    Biospecimen Acquisition Anatomical location of blood draw Capillary
    Vein

You Recently Viewed  

News and Announcements

  • Most Downloaded SOPs in 2024

  • New Articles on the GTEx Project are Now FREELY Available!

  • Just Published!

  • More...